Tag: Tiotropium Bromide

Lupin, Mark Cuban’s Cost Plus Drugs and COPD Foundation boost COPD treatment access

businessnewstoday- September 6, 2023

In a significant healthcare development, global pharmaceutical giant Lupin Limited (Lupin) has entered into a groundbreaking collaboration with Mark Cuban Cost Plus Drug Company (Cost ... Read More

Lupin clinches FDA approval for generic Spiriva HandiHaler

businessnewstoday- June 21, 2023

Indian pharma titan Lupin has announced receiving approval from the US Food and Drug Administration (FDA) for its Abbreviated New Drug Application for Tiotropium Bromide ... Read More

Lupin gets Health Canada approval for generic Spiriva for COPD treatment

businessnewstoday- May 27, 2023

Lupin has announced that its subsidiary in Canada, Lupin Pharma Canada has received approval from Health Canada to market a generic version of Spiriva (tiotropium ... Read More

Lupin bags UK approval for Lutio inhalation product for COPD treatment

pallavi123- August 26, 2022

Lupin through its subsidiary — Lupin Healthcare (UK) has secured approval from the UK Medicines and Healthcare products Regulatory Agency (MHRA) for Lutio, a generic ... Read More

Glenmark Pharmaceutical launches Tiogiva in UK for COPD treatment

pallavi123- June 15, 2021

Glenmark Pharmaceutical has announced the UK launch of Tiogiva, a bioequivalent version of Tiotropium Bromide dry powder inhaler (DPI), for the treatment of chronic obstructive ... Read More